Thatch hits $1B valuation after $108M round from existing backers
Health benefits startup Thatch has raised $108 million in new funding at a $1 billion valuation, backed by existing investors including Andreessen Horowitz, General Catalyst, Index Ventures, and The General Partnership. The round comes just 17 months after Thatch was valued at $410 million, with CEO Chris Ellis saying annual recurring revenue grew roughly sevenfold in that span.
GoKawiil's interpretation of the reporting above, not reported fact.
Thatch's rapid valuation growth reflects mounting pressure on employers facing the steepest projected healthcare cost increases since 2003, alongside worker demand for treatments like GLP-1 drugs that standard plans often exclude. By using the ICHRA/CHOICE model to let employees pick individual plans with employer-funded budgets, Thatch offers a structural alternative to traditional group insurance negotiations, potentially reshaping how companies manage benefits spending.
- Thatch raised $108M at a $1B valuation, up from $410M just 17 months earlier.
- The company's ARR grew about sevenfold, driven by rising employer healthcare costs and demand for drugs like Ozempic.
- Thatch uses the ICHRA/CHOICE model, letting employers fund fixed budgets for employees to choose individual plans via AI-driven recommendations.
Source: techcrunch.com — Marina Temkin, 2026-09-15
Published there as: “Health benefits platform Thatch reaches $1B valuation as healthcare costs surge”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.